E.U. Pays Gilead For Large Supply Of Remdisivir

by davidscott

The European Union agreed to pay more than 1 billion euros to Gilead for a six-month supply of its antiviral drug remdesivir, shortly before the publication of final results for the biggest trial of the COVID-19 medication.

 

 

Leave a Comment

DONATE NOW